1. Ronco G et al. Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials. Lancet 2014; 383: 524-32.
2. S3-Leitlinie Prävention des Zervixkarzinoms Langversion 1.0 – Dezember 2017 AWMF-Registernummer 015/027OL.
3. Meijer CJ et al. Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older. Int J Cancer 2009; 124: 516-20.
4. Stoler MH et al. The expanded use of HPV testing in gynecologic practice per ASCCP-guided management requires the use of well-validated assays. Am J Clin Pathol 2007; 127: 335-7.